Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of “Humanized” Multiple Sclerosis-like Disease*

Background: HLA-DR15 haplotype (DRB1*15:01-DQA1*01:02-DQB1*0602-DRB5*01:01) association with multiple sclerosis (MS) is conventionally attributed to effects from HLA-DRB1*15:01, with impact on MS risk from the neighboring HLA-DQ locus unclear. Results: Functional studies show MS-like disease dependent on a novel DQA1*01:02;DRB1*15:01 mixed isotype heterodimer. Conclusion: DQA1*01:02 within a mixed heterodimer may contribute to MS pathogenesis. Significance: HLA class II/MS susceptibility models may require broader reinterpretation. Gene-wide association and candidate gene studies indicate that the greatest effect on multiple sclerosis (MS) risk is driven by the HLA-DRB1*15:01 allele within the HLA-DR15 haplotype (HLA-DRB1*15:01-DQA1*01:02-DQB1*0602-DRB5*01:01). Nevertheless, linkage disequilibrium makes it difficult to define, without functional studies, whether the functionally relevant effect derives from DRB1*15:01 only, from its neighboring DQA1*01:02-DQB1*06:02 or DRB5*01:01 genes of HLA-DR15 haplotype, or from their combinations or epistatic interactions. Here, we analyzed the impact of the different HLA-DR15 haplotype alleles on disease susceptibility in a new “humanized” model of MS induced in HLA-transgenic (Tg) mice by human oligodendrocyte-specific protein (OSP)/claudin-11 (hOSP), one of the bona fide potential primary target antigens in MS. We show that the hOSP-associated MS-like disease is dominated by the DRB1*15:01 allele not only as the DRA1*01:01;DRB1*15:01 isotypic heterodimer but also, unexpectedly, as a functional DQA1*01:02;DRB1*15:01 mixed isotype heterodimer. The contribution of HLA-DQA1/DRB1 mixed isotype heterodimer to OSP pathogenesis was revealed in (DRB1*1501xDQB1*0602)F1 double-Tg mice immunized with hOSP(142–161) peptide, where the encephalitogenic potential of prevalent DRB1*1501/hOSP(142–161)-reactive Th1/Th17 cells is hindered due to a single amino acid difference in the OSP(142–161) region between humans and mice; this impedes binding of DRB1*1501 to the mouse OSP(142–161) epitope in the mouse CNS while exposing functional binding of mouse OSP(142–161) to DQA1*01:02;DRB1*15:01 mixed isotype heterodimer. This study, which shows for the first time a functional HLA-DQA1/DRB1 mixed isotype heterodimer and its potential association with disease susceptibility, provides a rationale for a potential effect on MS risk from DQA1*01:02 through functional DQA1*01:02;DRB1*15:01 antigen presentation. Furthermore, it highlights a potential contribution to MS risk also from interisotypic combination between products of neighboring HLA-DR15 haplotype alleles, in this case the DQA1/DRB1 combination.

[1]  M. Carrington,et al.  Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects , 2013, PLoS genetics.

[2]  W. Brown,et al.  Breadth of the CD4+ T cell response to Anaplasma marginale VirB9-1, VirB9-2 and VirB10 and MHC class II DR and DQ restriction elements , 2012, Immunogenetics.

[3]  H. Lassmann,et al.  DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP) , 2012, Journal of Neuroinflammation.

[4]  Simon C. Potter,et al.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.

[5]  M. Eisenstein,et al.  Computational mapping of anchoring spots on protein surfaces. , 2010, Journal of molecular biology.

[6]  S. Baranzini,et al.  Multiple sclerosis genetics—is the glass half full, or half empty? , 2010, Nature Reviews Neurology.

[7]  H. Lassmann,et al.  HLA-DQB1*0602 Determines Disease Susceptibility in a New “Humanized” Multiple Sclerosis Model in HLA-DR15 (DRB1*1501;DQB1*0602) Transgenic Mice1 , 2009, The Journal of Immunology.

[8]  Sreeram V Ramagopalan,et al.  Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility , 2009, Proceedings of the National Academy of Sciences.

[9]  M. Eisenstein,et al.  Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M). , 2008, International immunology.

[10]  Moses Rodriguez,et al.  HLA-DQ6 (DQB1*0601)-Restricted T Cells Protect against Experimental Autoimmune Encephalomyelitis in HLA-DR3.DQ6 Double-Transgenic Mice by Generating Anti-Inflammatory IFN-γ1 , 2008, The Journal of Immunology.

[11]  A. Ben-nun,et al.  Oligodendrocyte‐specific protein is encephalitogenic in rhesus macaques and induces specific demyelination of the optic nerve , 2008, European journal of immunology.

[12]  M. Eisenstein,et al.  OSP/claudin‐11‐induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic region OSP179–207 , 2007, European journal of immunology.

[13]  H. Lassmann,et al.  Epitope Specificity of Autoreactive T and B Cells Associated with Experimental Autoimmune Encephalomyelitis and Optic Neuritis Induced by Oligodendrocyte-Specific Protein in SJL/J Mice1 , 2006, The Journal of Immunology.

[14]  S. Hauser,et al.  The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration , 2006, Neuron.

[15]  Lon R. Cardon,et al.  Functional epistasis on a common MHC haplotype associated with multiple sclerosis , 2006, Nature.

[16]  M. Eisenstein,et al.  Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): Prime role of MOG44F in selection and control of MOG‐reactive T cells in H‐2b mice , 2006, European journal of immunology.

[17]  Moses Rodriguez,et al.  HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice , 2005, Journal of Neuroimmunology.

[18]  Gerrit Groenhof,et al.  GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..

[19]  R. Hohlfeld,et al.  Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[21]  M. Eisenstein,et al.  The Myelin-Associated Oligodendrocytic Basic Protein Region MOBP15–36 Encompasses the Immunodominant Major Encephalitogenic Epitope(s) for SJL/J Mice and Predicted Epitope(s) for Multiple Sclerosis-Associated HLA-DRB1*15011 , 2004, The Journal of Immunology.

[22]  L. Fugger,et al.  Myelin oligodendrocyte glycoprotein‐35–55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA‐DR2‐transgenic mice , 2004, European journal of immunology.

[23]  J. Trowsdale,et al.  MHC class II sequences of an HLA-DR2 narcoleptic , 2004, Immunogenetics.

[24]  Moses Rodriguez,et al.  HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis. , 2003, International immunology.

[25]  D. Baker,et al.  Encephalitogenic and immunogenic potential of myelin-associated glycoprotein (MAG), oligodendrocyte-specific glycoprotein (OSP) and 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in ABH and SJL mice , 2002, Journal of Neuroimmunology.

[26]  T‐cell responses to oligodendrocyte‐specific protein in multiple sclerosis , 2001, Journal of neuroscience research.

[27]  A. Meshorer,et al.  T-cells specific for soluble recombinant oligodendrocyte-specific protein induce severe clinical experimental autoimmune encephalomyelitis in H-2b and H-2s mice , 2000, Journal of Neuroimmunology.

[28]  G. Ellison,et al.  A humoral response to oligodendrocyte-specific protein in MS , 1999, Neurology.

[29]  L. Fugger,et al.  Functional characterization of HLA-DRA1*0101/DRB1*0401 molecules expressed in Drosophila melanogaster cells. , 2008, Tissue antigens.

[30]  Don C. Wiley,et al.  Crystal Structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a Peptide from Human Myelin Basic Protein , 1998, The Journal of experimental medicine.

[31]  A. Ben-nun,et al.  T-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein. , 1998, Journal of autoimmunity.

[32]  J. Bronstein,et al.  Oligodendrocyte‐specific protein (OSP) is a major component of CNS myelin , 1997, Journal of neuroscience research.

[33]  J. Bronstein,et al.  Isolation and characterization of a novel oligodendrocyte-specific protein , 1996, Neurology.

[34]  J. Strominger,et al.  Expression of Recombinant HLA-DR2 Molecules , 1996, The Journal of Biological Chemistry.

[35]  J. Hillert,et al.  The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. , 1995, Tissue antigens.

[36]  H. Inoko,et al.  The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4 , 1995, The Journal of experimental medicine.

[37]  J. Bodmer,et al.  HLA Class II nucleotide sequences, 1992. , 1993, Immunobiology.

[38]  J. Hillert,et al.  HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. , 1991, Tissue antigens.

[39]  H. Weiner,et al.  T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis , 1990, Nature.

[40]  V. Lotteau,et al.  Modulation of HLA class II antigen expression by transfection of sense and antisense DR alpha cDNA , 1989, The Journal of experimental medicine.

[41]  V. Lotteau,et al.  A novel HLA class II molecule (DRα–sDQβ) created by mismatched isotype pairing , 1987, Nature.

[42]  L. Hood,et al.  Cotransfer of the Ed alpha and Ad beta genes into L cells results in the surface expression of a functional mixed-isotype Ia molecule. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R. Knobler,et al.  Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition , 1985, The Journal of experimental medicine.

[44]  J. D. Capra,et al.  Allelic polymorphism and transassociation of molecules encoded by the HLA-DQ subregion. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Penninger,et al.  Brief Definitive Report , 2003 .

[46]  V. Lotteau,et al.  Hybrid HLA-DC antigens provide molecular evidence for gene trans-complementation , 1984, Nature.

[47]  H. Mcdevitt,et al.  Gene conversion between murine class II major histocompatibility complex loci. Functional and molecular evidence from the bm 12 mutant , 1984, The Journal of experimental medicine.

[48]  A. Ben-nun,et al.  Detection of autoimmune cells proliferating to myelin basic protein and selection of T cell lines that mediate experimental autoimmune encephalomyelitis (EAE) in mice. , 1983, Journal of immunology.

[49]  J. Mussini,et al.  [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.

[50]  I. Cohen,et al.  Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein , 1981, Nature.

[51]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.